Examining amyloid reduction as a surrogate endpoint through latent class analysis using clinical trial data for dominantly inherited Alzheimer's disease
- Guoqiao Wang
- , Yan Li
- , Chengjie Xiong
- , Tammie L.S. Benzinger
- , Brian A. Gordon
- , Jason Hassenstab
- , Andrew J. Aschenbrenner
- , Eric McDade
- , David B. Clifford
- , Jorge J. Libre-Guerra
- , Xinyu Shi
- , Catherine J. Mummery
- , Christopher H. van Dyck
- , James J. Lah
- , Lawrence S. Honig
- , Gregg Day
- , John M. Ringman
- , William S. Brooks
- , Nick C. Fox
- , Kazushi Suzuki
- Institute of Clinical and Translational Sciences (ICTS)
- Institute for Informatics, Data Science and Biostatistics (I2DB)
- Center for Biostatistics and Data Science (CBDS)
- Section of Neuroradiology
- Roy and Diana Vagelos Division of Biology & Biomedical Sciences (DBBS)
- DBBS - Biomedical Informatics and Data Science
- DBBS - Neurosciences
- Hope Center for Neurological Disorders
- Neuroimaging Labs Research Center
- Siteman Cancer Center
- Department of Neurology
- Section of Neuroinfectious Disease
- Section of Aging & Dementia
- Brain Tumor Center
Research output: Contribution to journal › Article › peer-review
9
Link opens in a new tab
Scopus
citations